Left Atrial Appendage Closure with Watchman vs Amulet Devices: Similarities and Differences

Area of Science:

• Cardiology
• Medical Devices
• Stroke Prevention

Background:

• Left atrial appendage closure (LAAC) is increasingly used for stroke prophylaxis in non-valvular atrial fibrillation (AF).
• Patients intolerant to oral anticoagulation (OAC) are primary candidates for LAAC procedures.
• Two FDA-approved endocardial devices, Watchman FLX and Amplatzer Amulet, are available for LAAC.

Purpose of the Study:

• To review current data on the efficacy and safety of LAAC devices.
• To compare the performance of Watchman FLX and Amplatzer Amulet for stroke prevention in AF.
• To assess the role of LAAC as an alternative to OAC.

Main Methods:

• Review of current clinical data and studies on LAAC devices.
• Comparison of efficacy and safety outcomes between Watchman FLX and Amplatzer Amulet.
• Analysis of peri-device leaks, device-related thrombosis, and mortality rates.

Main Results:

• Both Watchman FLX and Amplatzer Amulet demonstrate similar efficacy and safety for LAAC.
• Short- to long-term outcomes, including peri-device leaks and thrombosis, are comparable between the two devices.
• Differences exist in intraprocedural complication rates, but overall outcomes remain similar.

Conclusions:

• LAAC with both Watchman FLX and Amplatzer Amulet is a viable alternative for stroke prevention in AF patients intolerant to OAC.
• Both devices present similar risk and safety profiles, supporting their use in indicated patients.
• Ongoing research aims to establish LAAC as a primary stroke prevention strategy in AF.